GlassScriptPhysician profile
Ingrid Lidia Roig
NPI 1881847002
$646.08
in general payments reported to CMS, 2019-2025
6 companies · $52.55 in 2025
The $52.55 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.45 · 2022: $48.72 · 2023: $191 · 2024: $315 · 2025: $52.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293 · Education: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.35 |
| Education | $265.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $233.77 | 2023-2024 | Xerava, Xacduro |
| Insmed, INC. | $198.71 | 2020-2025 | Arikayce, Brinsupri |
| Astellas Pharma US INC | $166.98 | 2024 | |
| Melinta Therapeutics, LLC | $24.41 | 2024 | Vabomere, Orbactiv, Kimyrsa |
| Alexion Pharmaceuticals, INC. | $22.21 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Roig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.